Reactions 1680, p294 - 2 Dec 2017 Wound healing failure: case report A 51-year-old man developed wound healing failure following the therapy with ramucirumab. The man had metastatic stage IV lung adenocarcinoma. He had received carboplatin, pemetrexed and bevacizumab. However, due to disease progression, his medication was altered to docetaxel and ramucirumab 10 mg/kg [route not stated]. After two weeks of cycle 1, he underwent right jugular port placement for the adenocarcinoma. Six days later, he received another cycle of docetaxel and ramucirumab using a peripheral access, since the chest wall site was noted not to have healed. A third cycle of docetaxel and ramucirumab was administered peripherally after one month of the port placement. The chest incision site was noted to be tender with incomplete healing. One week later, the port site and venotomy incisions were not well apposed, with mild exudate from the incision. It was then revealed that the wound healing failure was due to the ramucirumab therapy. The man’s ramucirumab therapy was discontinued. He then received treatment with cefalexin. After one month, there was slight improvement in the port reservoir site, but the venotomy site was open and had not improved. The port was then removed and then a new port placed on the left side. Author comment: "In this case, the poor wound healing likely represents an adverse effect of ramucirumab". Zhan C, et al. Wound Healing Failure Following Venous Access Chest Port Placement Associated with Ramucirumab Therapy. Cardiovascular and Interventional Radiology 40: 1804-1806, No. 11, Nov 2017. Available from: URL: http://doi.org/10.1007/s00270-017-1752-8 - USA 803285097 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud